Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (ERBB2/HER2) are considered as the molecular markers for diagnostic classification of breast cancer subtypes [6, 7]. This evidence concerns the gene ERBB2 and breast carcinoma.